What is immunotherapy, and how is it used in pediatric cancer treatment?
Mechanisms of Immunotherapy
- Boosting the Immune System
- General Stimulation: Some immunotherapies work by stimulating the immune system broadly to enhance its response against cancer cells.
- Sources: National Cancer Institute, American Cancer Society
- Targeting Specific Cancer Cells
- Monoclonal Antibodies: These are lab-made molecules that can bind to specific targets on cancer cells. They mark the cancer cells for the immune system to destroy.
- Sources: American Cancer Society, St. Jude Children's Research Hospital
- Checkpoint Inhibitors
- Mechanism: These drugs block proteins that prevent the immune system from attacking cancer cells, thereby boosting the immune response against cancer.
- Sources: National Cancer Institute, American Cancer Society
Types of Immunotherapy Used in Pediatric Cancer
- CAR T-Cell Therapy
- Description: Involves modifying a patient's T cells to better recognize and attack cancer cells. These engineered cells are then infused back into the patient.
- Use in Pediatrics: Particularly effective in treating certain types of leukemia and lymphoma.
- Sources: National Cancer Institute, Children's Hospital of Philadelphia
- Monoclonal Antibodies
- Description: These antibodies are designed to bind to specific targets on cancer cells and either directly destroy the cells or mark them for destruction by the immune system.
- Use in Pediatrics: Used in treating various pediatric cancers, including neuroblastoma and certain leukemias.
- Sources: American Cancer Society, St. Jude Children's Research Hospital
- Checkpoint Inhibitors
- Description: Drugs like pembrolizumab and nivolumab block checkpoint proteins that inhibit the immune response, allowing T cells to better attack cancer cells.
- Use in Pediatrics: Emerging as a treatment option for various pediatric cancers, including Hodgkin lymphoma and melanoma.
- Sources: National Cancer Institute, American Cancer Society
Benefits of Immunotherapy
- Targeted Action
- Immunotherapy specifically targets cancer cells while sparing healthy cells, leading to fewer side effects compared to traditional treatments like chemotherapy and radiation.
- Sources: National Cancer Institute, American Cancer Society
- Durable Responses
- Some immunotherapies provide long-lasting protection against cancer by creating a memory in the immune system.
- Sources: American Cancer Society, St. Jude Children's Research Hospital
Side Effects and Management
- Common Side Effects
- Fatigue, fever, chills, nausea, and infusion reactions are common side effects of immunotherapy.
- Sources: American Cancer Society, Mayo Clinic
- Managing Side Effects
- Close monitoring and supportive care are essential to manage side effects. Healthcare providers may prescribe medications to alleviate symptoms.
- Sources: National Cancer Institute, American Cancer Society
Conclusion
Immunotherapy represents a promising advancement in pediatric cancer treatment, harnessing the body's immune system to fight cancer more effectively and with potentially fewer side effects than traditional therapies. Through various mechanisms such as CAR T-cell therapy, monoclonal antibodies, and checkpoint inhibitors, immunotherapy offers new hope for children battling cancer.Further Reading
These resources provide comprehensive information on how immunotherapy works and its role in treating pediatric cancer.Please login or Register to submit your answer